Gastric cancer (GC) is one of the most common malignant tumors of digestive systems
worldwide, with high recurrence and mortality. Chemotherapy is still the standard treatment …

Gastric cancer is the third most common cause of cancer-related death worldwide. Drug
resistance is the main inevitable and vital factor leading to a low 5-year survival rate for …

Background Breast cancer (BC) is by far the most common malignancy among women.
Epigenetic modulators, microRNAs in particular, may set stages for BC development and its …

Breast cancer is a complex disease exhibiting a great degree of heterogeneity due to
different molecular subtypes. Notch signaling regulates the differentiation of breast epithelial …

Simple Summary Non-coding RNAs are a type of RNA that is not translated into proteins.
They play important roles in several cellular processes, mainly in the regulation of genetic …

Colorectal cancer (CRC) is one of the most common cancers globally. Although a variety of
CRC screening methods have been developed, many patients are diagnosed at advanced …

Cisplatin is the first-line drug for gastric cancer (GC). Cisplatin resistance is the most
important cause of poor prognosis for GC. Increasing evidence has identified the important …

Gastric cancer (GC) is one of the most lethal malignancies worldwide. However, the
molecular mechanisms underlying gastric carcinogenesis remain largely unknown. Over the …

Gastric cancer (GC) is one of the most commonly diagnosed neoplasms in the world. A
number of environmental and lifestyle factors, particularly chronic infection with Helicobacter …

Aims The potential of all-trans retinoic acid (ATRA) in regulating some microRNAs (miRNAs)
involved in multiple cancer-related pathways, including resistance to chemotherapeutics …